Bio-tech
RESULTS 1-10 of 624
NeoStem CEO Discusses Adult Stem Cell Therapies
May 14 (Bloomberg) -- Robin Smith, chief executive officer of NeoStem Inc., talks about the company's use of non-embryonic stem cells to create cel...
Utah Mother Gets No Answer About Baby's DNA Fate
May 14 (Bloomberg) -- Halena Black's family in Ogden, Utah, is at the center of a growing ethical debate involving people who undergo DNA testing f...
Pathologist Leonard on Genetic Sequencing Ethics
May 14 (Bloomberg) -- Debra Leonard, a pathologist at Weill Cornell Medical College, and Gholson Lyon, a genetics researcher at Cold Spring Harbor ...
Friday Sector Leaders: General Contractors & Builders, Biotechnology Stocks
In trading on Friday, general contractors & builders shares were relative leaders, up on the day by about 1.3%. Leading the group were shares of Ho...
Local company lands Homeland Security contract
What if a pin prick of blood and ten minutes could tell if you actually have the flu or if you have fallen victim to an outbreak? A Sarasota biotec...
Pfizer Needs More New Products, Butler Says
May 1 (Bloomberg) -- Tony Butler, an analyst at Barclays Capital, talks about Pfizer Inc.'s first-quarter profit and the outlook for the company's ...
Sanofi CEO on Growth Prospects, Acquisitions
May 1 (Bloomberg) -- Chris Viehbacher, chief executive officer of Sanofi, talks about the French drugmaker's sales in Europe and the U.S., growth p...
Sanofi CEO on Growth Prospects, Acquisitions
April 30 (Bloomberg) -- Chris Viehbacher, chief executive officer of Sanofi, talks about the French drugmaker's sales in Europe and the U.S., growt...
Monday Sector Leaders: Specialty Retail, Biotechnology Stocks
In trading on Monday, specialty retail shares were relative leaders, up on the day by about 1.3%. Leading the group were shares of Barnes & Noble (...
